Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing

BACKGROUND: Regulatory approval of next generation sequencing (NGS) by the FDA is advancing the use of genomic-based precision medicine for the therapeutic management of cancer as standard care. Recent FDA guidance for the classification of genomic variants based on clinical evidence to aid clinicia...

Descripción completa

Detalles Bibliográficos
Autores principales: Dy, Grace K., Nesline, Mary K., Papanicolau-Sengos, Antonios, DePietro, Paul, LeVea, Charles M., Early, Amy, Chen, Hongbin, Grand’Maison, Anne, Boland, Patrick, Ernstoff, Marc S., Edge, Stephen, Akers, Stacey, Opyrchal, Mateusz, Chatta, Gurkamal, Odunsi, Kunle, Pabla, Sarabjot, Conroy, Jeffrey M., Glenn, Sean T., DeFedericis, Hanchun T., Burgher, Blake, Andreas, Jonathan, Giamo, Vincent, Qin, Maochun, Wang, Yirong, Kanehira, Kazunori, Lenzo, Felicia L., Frederick, Peter, Lele, Shashikant, Galluzzi, Lorenzo, Kuvshinoff, Boris, Morrison, Carl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339275/
https://www.ncbi.nlm.nih.gov/pubmed/30658646
http://dx.doi.org/10.1186/s12911-019-0743-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339275/
https://www.ncbi.nlm.nih.gov/pubmed/30658646
http://dx.doi.org/10.1186/s12911-019-0743-x

Ejemplares similares